You don’t have any Active Subscription.
Subscribed with another email? Logout and Login with that one.
Your active subscription(s)
Account subscription benefits alongside Premium Stories, Editorials, Opinions and more. Unlock these with Subscription
Products you've access to
Additional Subscription Benefits
Need help with your subscription?
Published - October 22, 2026 11:55 pm IST - GUNTUR
Dr. Kalyan Chakravarthy Koganti, the researcher, sepsis and infectious diseases specialist at SHRI Hospital, along with the research team in Guntur on Thursday. | Photo Credit: T. Vijaya Kumar
Research into bacteriophage therapy in Guntur has made promising progress, with a local medical team reporting success in treating multidrug-resistant infections. The findings have been published in the International Journal of Infectious Diseases (IJID Regions), while the research has also received a biomedical research grant from the Sree Padmavathi Venkateswara Foundation.
Marking World Bacteriophage Day on Thursday and Bacteriophage Week from October 22 to 28, Dr. Kalyan Chakravarthy Koganti, the researcher, sepsis and infectious diseases specialist at SHRI Hospital, highlighted the team’s research and its potential benefits for patients who do not respond to conventional antibiotics.
A patient had suffered from a persistently discharging wound in his left knee caused by multidrug-resistant Pseudomonas aeruginosa. Despite multiple courses of antibiotics at different institutions, he had not achieved complete recovery. After approaching Dr. Kalyan and his team, he underwent phage therapy and recovered completely.
He has reportedly remained infection-free and has been able to walk for the past nine months, Dr. Kalyan informed.
Dr. Sutharsan Govindarajan, associate professor and phage biologist at SRM University-A.P., developed the required bacteriophages. Molecular biologist Dr. Sandeep Nadendla, CEO of Ipseity Diagnostics and Research, provided technical support.
Orthopaedician Dr. Raviteja Yarlagadda and critical care specialist Dr. Ramakrishna Prasad K. of SHRI Hospital extended clinical support. The team hopes its research will benefit more patients with drug-resistant infections.
Published - October 22, 2026 11:55 pm IST
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
